Small molecule inhibitor of NRF2 selectively intervenes therapeutic resistance in KEAP1-deficient NSCLC tumors

Loss of function mutations in Kelch Like ECH Associated Protein 1 (KEAP1) or gain-of-function mutations in nuclear factor erythroid 2-related factor 2 (NRF2) are common in non-small cell lung cancer (NSCLC) and is associated with therapeutic resistance. To discover novel NRF2 inhibitors for targeted...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:ACS Chem Biol
Hlavní autoři: Singh, Anju, Venkannagari, Sreedhar, Oh, Kyu H., Zhang, Ya-Qin, Rohde, Jason M., Liu, Li, Nimmagadda, Sridhar, Sudini, Kuladeep, Brimacombe, Kyle R., Gajghate, Sachin, Ma, Jinfang, Wang, Amy, Xu, Xin, Shahane, Sampada A., Xia, Menghang, Woo, Juhyung, Mensah, George A., Wang, Zhibin, Ferrer, Marc, Gabrielson, Edward, Li, Zhuyin, Rastinejad, Fraydoon, Shen, Min, Boxer, Matthew B., Biswal, Shyam
Médium: Artigo
Jazyk:Inglês
Vydáno: 2016
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5367156/
https://ncbi.nlm.nih.gov/pubmed/27552339
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acschembio.6b00651
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky